29 November 2021
Until recently, developing a vaccine was a time-consuming and costly process, involving the production of inactivated or weakened virus or viral proteins. It required a lot of trial and error to make these ‘artificial’ proteins look as close to the real thing as possible – a process scientists would have to repeat each time a virus mutates and changes its structure.
mRNA technology circumvents this iterative process and instead use our own cells to make the vaccine.
The process works so well because our cells already have all the machinery they need to build perfect copies of proteins. All we need to supply is the instructions. Because these instructions only code for a small part of a virus, there’s zero chance that our cells will accidentally make the real thing.
Nestled in the nucleus, at the centre of our cells, is our DNA. It contains the instructions to produce most of the building blocks, or proteins, that make up our body.
However, DNA never ventures out of its position within the fortified nucleus. Instead, it sends out a tiny messenger molecules – mRNA – which contain only the relevant instructions for our cells to make particular proteins. This intermediate messenger is required because the machinery for making proteins lives outside the nucleus. Once the information in the mRNA is read by the cell and made into a protein, it’s no longer needed and breaks down.
Because viruses are also made of proteins, by presenting the body with an mRNA molecule encoding a portion of the virus, like a spike on its surface, we can get a cell to produce copies of this protein, which then get picked up by our immune cells that can now begin the process of recognising and generating immunity.
To make a new vaccine, all we need is to know the genetic code of the virus, a process that takes only a few hours. Once we know the code we can determine which bits will work best for a vaccine and generate a matching mRNA sequence. All up, it takes only a couple of days and very few resources to have a brand new vaccine, compared to sometimes years using the traditional method. Once it’s gone through the safety testing, billions of doses can be made and distributed from a single lab.
Samoa Capital Radio - science series with the Malaghan Institute
22 June 2022
Dr Kerry Hilligan awarded HRC Emerging Researcher First Grant
31 May 2022
Homegrown COVID-19 booster vaccine: building New Zealand’s biomedical capability
23 May 2022
In focus: Life in the whirlwind of COVID-19 vaccine research
18 May 2022
International Day of Immunology 2022: Vaccine research enters a new era with mRNA technology
29 April 2022
Inaugural Te Urungi fellowship awarded to Dr Theresa Pankhurst
26 April 2022